Steven Schopler, MD
Orthopaedic Surgery of the Spine · van Nuys, CANPI 1417988791
Payments from drug & device makers
Across 37 payments — averaging $531.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$7K
- Arthrex$7K
- Globus Medical$4K
- Alphatec Spine, Inc$807
- Surgalign Spine Technologies, Inc.$219
- Amgen$148
- plus $91 from 3 others
Across 1 payment — averaging $21,900 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Globus Medical$22K
What the payments were for
- Royalty or licence$2191%
- Consulting fees$14,51377%
- Travel & lodging$3,27717%
- Food & beverage$9575%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 8 | $7,089 |
| Arthrex | 2 | $6,904 |
| Globus Medical | 18 | $4,403 |
| Alphatec Spine, Inc | 2 | $807 |
| Surgalign Spine Technologies, Inc. | 2 | $219 |
| Amgen | 2 | $148 |
| Sanara Medtech Inc. | 1 | $44 |
| Titan Spine, LLC | 1 | $28 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Apligraf$6,250
- Dermagraft$6,250
- Puraply/Affinity/NuTech$6,250
- RISE$1,593
- ELSA$1,364
- Excelsius - GPS$937
- Other - Miscellaneous$760
- Puraply, NuShield, Affinity$535
- Quartex$425
- Lateral Disc Prep I & II$238
- CROSS-FUSE II PEEK VBR/IBF SYSTEM$188
- Prolia$125
How this compares
$19,660 in reported general payments places this provider in the 50th percentile of 288 orthopaedic surgery of the spine providers in California.
See all orthopaedic surgery of the spine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 15 | $22 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in van Nuys
- Babak Barcohanavan Nuys$2.9M
- Brian Grossmanvan Nuys$415K
- Hyun BaeSanta Monica$62.2M
- Choll KimSan Diego$4M
- Stacey BedermanOrange$3.7M
- Gregory Mundisla Jolla$3.5M
- Neelakantan AnandLos Angeles$3.2M
- Paul SlosarDaly City$3.1M
- Rick DelamarterSanta Monica$2.3M
- Sanjay KhuranaMarina del Rey$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.